Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Fund Type: SICAV
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: Global

AXA World Funds - Framlington Health

+ Add to Watchlist

AFRHLFE:LX

258.44 EUR 1.67 0.65%

As of 00:59:30 ET on 01/29/2015.

Snapshot for AXA World Funds - Framlington Health (AFRHLFE)

Year To Date: +10.52% 3-Month: +20.95% 3-Year: +30.32% 52-Week Range: 165.30 - 262.43
1-Month: +10.17% 1-Year: +50.43% 5-Year: +23.99% Beta vs LUXXX: 0.65

Mutual Fund Chart for AFRHLFE

No chart data available.
  • AFRHLFE:LX 258.44
  • 1M
  • 1Y
Interactive AFRHLFE Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for AFRHLFE

AXA World Funds - Framlington Health is a SICAV incorporated in Luxembourg. The Fund will invest permanently at least two thirds of the total assets in equities and equities related instruments issued by companies engaged in healthcare and medical services and product worldwide.

Inception Date: 01-12-2007 Telephone: 352-44-24-24-1
Managers: GEMMA GAME / BRUNO GRANDSARD
Web Site: www.axa-im.lu

Fundamentals for AFRHLFE

NAV (on 2015-01-29) 258.44
Assets (M) (on 2015-01-29) 92.48
Fund Leveraged N
Minimum Investment 500,000.00
Minimum Subsequent Investment 10,000.00

Dividends for AFRHLFE

No dividends reported

Fees & Expenses for AFRHLFE

Front Load -
Back Load 0.00
Current Mgmt Fee 1.50
Redemption Fee 0.00
12b1 Fee -
Expense Ratio -

Top Fund Holdings for AFRHLFE

Filing Date: 11/28/2014
Name Position Value % of Total
Roche Holding AG 15,911 4,779,080 5.589%
Novartis AG 44,510 4,319,341 5.052%
Gilead Sciences Inc 37,625 3,774,540 4.415%
Amgen Inc 15,844 2,619,172 3.063%
AbbVie Inc 36,433 2,521,164 2.949%
UnitedHealth Group Inc 24,470 2,413,476 2.823%
Celgene Corp 19,208 2,183,758 2.554%
Express Scripts Holding Co 24,596 2,045,157 2.392%
McKesson Corp 9,046 1,906,535 2.230%
Medtronic PLC 25,362 1,873,491 2.191%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil